We receive and publish:
Paolo Pelini : EFSA's scientific assessment of the dangerousness of the effects of monacolin K contained in fermented red rice is completely anti-scientific in nature, like the many pseudo reports on natural 
recent and very political!
Here is what it indicates
In a 2018 scientific assessment the European Food Safety Authority (Efsa) had however raised doubts about the safety of these products because the intake of monacolin from red yeast rice through food supplements could lead to exposure to the active ingredient in the range of therapeutic doses of lovastatin. Furthermore, the adverse effect profile of red yeast rice is also similar to that of lovastatin; among those reported, the main ones concerned musculoskeletal and connective tissue (including rhabdomyolysis), liver, nervous system, gastrointestinal tract, skin and subcutaneous tissue.
From here EFSA concluded that 10 mg of monacolin from red yeast rice in food supplements could pose a public health problem.
Moreover, the same effects were observed – albeit in fewer numbers at lower doses. However, EFSA had not provided an opinion regarding a daily amount that would not give rise to health concerns in the general population but above all in vulnerable subgroups (the elderly, pregnant women...).
This thesis was, however, denied by the European Guidelines drawn up by the European Society of Cardiology and other Societies on the Prevention of Cardiovascular Diseases in Clinical Practice (2016), which in the paragraph dedicated to other treatments for dyslipidemia, textually report "Nutraceuticals containing purified RYR may be considered in people with elevated plasma cholesterol concentrations who do not qualify for treatment with statins in view of their global CV risk”.
EFSA apply Science and stop making politics against the natural!
Paul Pellini
Herbochemist
Evaluation and Pharmacognostic and Cytotoxicological Research on Plant Extracts of Medicinal Plants
E-mail: paolo.pelini@gmail.com
http://www.paolopelinierbochimico.it
Received in the editorial staff on 10.19.2022
NB: Any opinion, advice, statement or other work made available by third parties is not attributable nor is it necessarily shared by Fedaiisf but to the respective authors. Fedaiisf is not responsible for what is published by readers in the comments on the site or in any other connected platforms.
